STOCKS

RECOMMENDED BROKERS  
f
Comments Rating 4.84 (242 reviews)
f
Comments Rating 4.83 (241 reviews)
f
Comments Rating 4.86 (238 reviews)
Stocks, Stocks

AstraZeneca Beats Estimates Aided by Cancer Drugs

COVID-vaccine maker AstraZeneca beats the $10.73 billion consensus estimates with its $10.98 billion total revenue for Q3, aided by the sales of its cancer drugs. AstraZeneca, whose most extensive disease

Sending
User Review
0 (0 votes)